Results 181 to 190 of about 78,820 (216)

Associations between metabolic score for visceral fat and nonalcoholic fatty liver disease (NAFLD) in US adults: A cross-sectional study based on NHANES 2017-2020. [PDF]

Medicine (Baltimore)
Li J, Dai S.
europepmc   +1 more source

Health Benefits and Therapeutic Potential of Quercetin

Journal of Food Biochemistry, Volume 2026, Issue 1, 2026.
Quercetin, a polyphenolic compound prevalent in many fruits, vegetables, and other dietary sources, has attracted considerable interest due to its extensive health benefits. This review examines its diverse biological properties, particularly its antioxidant and anti‐inflammatory effects. The study integrates recent scientific findings to elucidate the
Mahendra Aryal, Kim Wei Chan
wiley   +1 more source

Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease. [PDF]

Am J Gastroenterol
Le P, Tatar M, Rothberg MB, Wilson LA, Allende D, Diehl AM, Loomba R, Chalasani N, Neuschwander-Tetri BA, Kowdley K, Sanyal AJ, Tonascia J, Dasarathy S, NASH Clinical Research Network (CRN).   +13 more
europepmc   +1 more source

Immune System and Hepatic Stellate Cells’ Crosstalk in Liver Fibrosis: Pathways and Therapeutic Potential

Journal of Immunology Research, Volume 2026, Issue 1, 2026.
Liver fibrosis, characterized by the excessive deposition of extracellular matrix (ECM) driven by hepatic stellate cells (HSCs) activation, remains a critical challenge due to its progression to cirrhosis and hepatocellular carcinoma (HCC). This review clarifies the complex crosstalk between the immune system and HSCs, highlighting key cellular players
Wahyu Widowati, Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Aris Muhamad Nurjamil, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Rizal Azis, Elham Rismani, Massoud Vosough, Poorani Gurumallesh Prabu   +10 more
wiley   +1 more source

Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease. [PDF]

Diabetol Metab Syndr
Yang L, Huang H, Wang Z, Xu C.
europepmc   +1 more source

Golgi‐Targeted Viscosity Fluorescent Probe for Monitoring Acute Lung Injury

Chemistry – A European Journal, Volume 31, Issue 70, December 12, 2025.
In this study, we present a novel Golgi‐targeted fluorescent probe, GV, designed for highly sensitive and selective monitoring of viscosity changes during Golgi stress in an acute lung injury (ALI) model. GV was successfully applied to visualize elevated Golgi viscosity in living cells under various stimuli. More importantly, we directly demonstrated a
Yaqian Li, Zi Yang, Jieni Lei, Qiuzi Dai, Guangyi Li, Hai Xu, Jiaoyang Lu, Juyoung Yoon   +7 more
wiley   +1 more source

Triglyceride-glucose index associated with anthropometric parameters: Early markers in the progression of nonalcoholic fatty liver disease. [PDF]

Hepatol Forum
da Silva ES, Locatelli C.
europepmc   +1 more source

SLC11A1 protein as a key regulator of iron metabolism, ferroptosis mediator, and putative therapeutic target in nonalcoholic fatty liver disease: an integrated bioinformatics analysis. [PDF]

Front Pharmacol
Wang Y, Zhou B, Li S, Zheng L, Huang X, Wang H, Li S, Lin Y, Xu Y.   +8 more
europepmc   +1 more source

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis. [PDF]

BMC Gastroenterol
Ren W, Wang Z, Liu X, Liu X, Ma D, Jin Q, Wang J, Feng J, Rao H, Wang X, Huang R.   +10 more
europepmc   +1 more source

Causal association between macrophage migration inhibitory factor and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study. [PDF]

Medicine (Baltimore)
Yu F, Fang Y, Fang P, Chen D.
europepmc   +1 more source